Jupiter Asset Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-53,078
Closed -$1.06M 397
2024
Q1
$1.06M Sell
53,078
-97,431
-65% -$1.88M 0.01% 364
2023
Q4
$3.38M Buy
150,509
+526
+0.4% +$10.9K 0.03% 287
2023
Q3
$3.03M Buy
149,983
+105,100
+234% +$2.38M 0.03% 293
2023
Q2
$1.15M Buy
44,883
+15,180
+51% +$400K 0.01% 420
2023
Q1
$883K Buy
29,703
+4,217
+17% +$122K 0.01% 349
2022
Q4
$690K Buy
25,486
+12,354
+94% +$302K 0.01% 394
2022
Q3
$286K Hold
13,132
﹤0.01% 486
2022
Q2
$359K Buy
+13,132
New +$377K 0.01% 516

Other funds holding AVNS

Jupiter Asset Management's AVNS Position: Q2 2024 in Review

Jupiter Asset Management sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 53,078 shares — an estimated $1.06M sold.

Jupiter Asset Management first reported a position in AVNS in Q2 2022 and held it in 8 quarters. The position peaked at $3.38M in Q4 2023. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • Jupiter Asset Management reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • Jupiter Asset Management sold 53,078 Avanos Medical shares in Q2 2024, an estimated $1.06M.
  • Jupiter Asset Management first reported a position in Avanos Medical in Q2 2022 and held it in 8 quarters.
  • Jupiter Asset Management's Avanos Medical position peaked at $3.38M in Q4 2023.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Jupiter Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.